Aaron Wealth Advisors
TTRX icon

Aaron Wealth Advisors’s Turn Therapeutics TTRX Stock Holding History

Aaron Wealth Advisors’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$469K Hold
32,564
– – 0.02% 462
2026
Q2 		$238K Buy
+32,564
New +$151K 0.01% 641

Other funds holding TTRX

SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
IEQ Capital
IEQ Capital Foster City, California $23.5B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $508M AUM 11.76% 1-Year Est. Return
Tamar Securities
Tamar Securities Woodland Hills, California $1.12B AUM 21.31% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
McCarthy Asset Management
McCarthy Asset Management Redwood Shores, California $209M AUM
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Aaron Wealth Advisors's TTRX Position: Q3 2026 in Review

Aaron Wealth Advisors held its Turn Therapeutics (TTRX) position steady in Q3 2026 at 32,564 shares worth $469K. The position accounts for 0.02% of the portfolio, ranked #462.

Aaron Wealth Advisors first reported a position in TTRX in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold TTRX as of Q3 2026.

  • Aaron Wealth Advisors held 32,564 shares of Turn Therapeutics worth $469K as of Q3 2026.
  • Aaron Wealth Advisors left its Turn Therapeutics share count unchanged in Q3 2026.
  • Turn Therapeutics made up 0.02% of Aaron Wealth Advisors's portfolio in Q3 2026, its #462 holding.
  • Aaron Wealth Advisors first reported a position in Turn Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Turn Therapeutics as of Q3 2026.

Based on Aaron Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.